The second model showed that HT patients carrying the APOA5 p.19W allele exhibit an increased risk of presenting mixed hyperlipidemia (OR = 8.8; 95% CI: 1.76–44.0; P = 0.02) under the recessive model (WW v. This evidence concerns the gene APOA5 and hematocrit.